Cagent Vascular has announced the initiation of the PRELUDE-BTK study. According to a press release, the purpose of this prospective, single-arm, multicentre feasibility study is to show the safety and efficacy of the Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter in infrapopliteal arteries. Andrew Holden (University of Auckland, Auckland Hospital, Auckland, New Zealand) [...]